Customers Bancorp, Inc.

**Signal Note:** Driehaus Capital's $56M entry into Customers Bancorp (CUBB) appears incongruent with the firm's growth biotech focus, suggesting either portfolio diversification or a conviction thesis on regional banking sector fundamentals. This positioning shift warrants monitoring for whether it reflects broader macro conviction or represents a tactical allocation adjustment, though it lacks the biotech-specific catalysts typical of Driehaus's core strategy.